Mitchell Blutt, MD

Mitchell Blutt, MD is the CEO of Consonance Capital, a health care focused investment
firm. He is the former Executive Partner of J.P. Morgan Partners (JPMP). He is a Clinical
Assistant Professor of Medicine, in the Department of Medicine at Weill Cornell Medicine.

Dr. Blutt completed his BA and MD degrees at the University of Pennsylvania and he
received his MBA from the Wharton School of the University of Pennsylvania through the
Clinical Scholars Fellowship sponsored by the Robert Wood Johnson Foundation. He
completed his residency in Internal Medicine at New York-Presbyterian/Weill Cornell
Medical Center.

Dr. Blutt has served on numerous boards of directors, including Cardinal Health, Cooper
Holding, DJ Orthopedics, Fisher Scientific, General Medical, Hanger Orthopedic Group,
Medical Arts Press, Tenax, Thermoscan and KEPRO. He also formerly served on the Board
of the Michael J. Fox Foundation for Parkinson’s Research, the Board of Trustees of Penn
Medicine (the Health System of the University of Pennsylvania), the Board of Trustees of
the University of Pennsylvania, and the Board of The Brearley School.

Dr. Blutt currently serves on numerous boards at the University of Pennsylvania including
the Board of Advisors of the School of Arts and Sciences and the Board of Advisors of the
Wharton School; he also serves as the Chairman of the External Advisory Board of CHIBE
(Center for Health Incentives and Behavioral Economics), and is a member of the External
Advisory Board of The Penn brainSTIM Center. Dr. Blutt is a recipient of the Alumni Award
of Merit, the University of Pennsylvania’s highest honor. Additionally, Dr. Blutt is a member
of the Board of Fellows of Weill Cornell Medicine and the Co-Chairman of its Special
Committee on Equity, Diversity and Inclusion; the Executive Committee of the Dean’s
Council, an advisory board to the Dean; the New York Weill Cornell Council, an advisory
board to the New York-Presbyterian/Weill Cornell Medical Center. He's also a member of
the External Board of Directors of CABM (Center for Advanced Biotechnology and
Medicine), Rutgers University. In addition, Dr. Blutt serves on the Board of Directors of The
Commonwealth Fund, a private foundation that supports independent research on health
and social issues and makes grants to improve health care practice and policy. Dr. Blutt is
also a member of the Board of Bako, a premier national provider of specialty laboratory
testing and other high quality pathology services, and PMC (Psychiatric Medical Care), the
leading operator of inpatient and outpatient behavioral health programs in rural
communities.

Dr. Blutt founded Consonance Capital in 2005.